Thiol/disulfide homeostasis: A prognostic biomarker for patients with advanced non-small cell lung cancer?

References

• Kocaturk C, Gunluoglu MZ, Cansever L, Dincer IS, Bedirhan MA. Prognosis in patients with non-small cell lung cancer and satellite tumors. Thorac Cardiovasc Surg 2011;59(6):360–3. doi: 10.1055/s-0030-1270799
   PubMed Web of Science ®Google Scholar
• Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82(1):47–95. doi: 10.1152/physrev.00018.2001
   PubMed Web of Science ®Google Scholar
• Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 2008;11(1):1–15. doi: 10.1080/10937400701436460
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39(1):44–84. doi: 10.1016/j.biocel.2006.07.001
   PubMed Web of Science ®Google Scholar
• Brennan P, Fortes C, Butler J, Agudo A, Benhamou S, Darby S, et al. A multicenter case–control study of diet and lung cancer among non-smokers. Cancer Causes Control 2000;11(1):49–58. doi: 10.1023/A:1008909519435
   PubMed Web of Science ®Google Scholar
• Esme H, Cemek M, Sezer M, Saglam H, Demir A, Melek H, et al. High levels of oxidative stress in patients with advanced lung cancer. Respirology 2008;13(1):112–6. doi: 10.1111/j.1440-1843.2007.01212.x
   PubMed Web of Science ®Google Scholar
• Chan HP, Tran V, Lewis C, Thomas PS. Elevated levels of oxidative stress markers in exhaled breath condensate. J Thorac Oncol 2009;4(2):172–8. doi: 10.1097/JTO.0b013e3181949eb9
   PubMed Web of Science ®Google Scholar
• Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention? BMC Med 2011;9:62. doi: 10.1186/1741-7015-9-62
   PubMed Web of Science ®Google Scholar
• da Motta LL, Müller CB, de Bastiani MA, Behr GA, França FS, da Rocha RF, et al. Imbalance in redox status is associated with tumor aggressiveness and poor outcome in lung adenocarcinoma patients. J Cancer Res Clin Oncol 2014;140(3):461–70. doi: 10.1007/s00432-014-1586-6
   PubMed Web of Science ®Google Scholar
• Blair SL, Heerdt P, Sachar S, Abolhoda A, Hochwald S, Cheng H, et al. Glutathione metabolism in patients with non-small cell lung cancers. Cancer Res 1997;57(1):152–55.
   PubMed Web of Science ®Google Scholar
• Karoui H, Hogg N, Fréjaville C, Tordo P, Kalyanaraman B. Characterization of sulfur-centered radical intermediates formed during the oxidation off thiols and sulfite by peroxynitrite – ESR-SPIN trapping and oxygen uptake studies. J Biol Chem 1996;271:6000–9. doi: 10.1074/jbc.271.11.6000
   PubMed Web of Science ®Google Scholar
• Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med 2013;65:244–53. doi: 10.1016/j.freeradbiomed.2013.05.050
   PubMed Web of Science ®Google Scholar
• Chianeh YR, Prabhu K. Protein thiols as an indicator of oxidative stress. Arch Med Rev J 2014;23(3):443–56.
   Google Scholar
• Taysi S, Polat F, Gul M, Sari RA, Bakan E. Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 2002;21(5):200–4. doi: 10.1007/s00296-001-0163-x
   PubMed Web of Science ®Google Scholar
• Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010;48(6):749–62. doi: 10.1016/j.freeradbiomed.2009.12.022
   PubMed Web of Science ®Google Scholar
• Erel O, Neselioglu S. A novel and automated assay for thiol/disulfide homeostasis. Clin Biochem 2014;47(18):326–32. doi: 10.1016/j.clinbiochem.2014.09.026
   PubMed Web of Science ®Google Scholar
• Güner G, Işlekel H, Oto O, Hazan E, Açikel U. Evaluation of some antioxidant enzymes in lung carcinoma tissue. Cancer Lett 1996;103(2):233–9. doi: 10.1016/0304-3835(96)04226-7
   PubMed Web of Science ®Google Scholar
• Yoo DG, Song YJ, Cho EJ, Lee SK, Park JB, Yu JH, et al. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implicationsof impaired extracellular superoxide dismutase and catalase antioxidant systems. Lung Cancer 2008;60(2):277–84. doi: 10.1016/j.lungcan.2007.10.015
   PubMed Web of Science ®Google Scholar
• Wang D, Xiang DB, Yang XQ, Chen LS, Li MX, Zhong ZY, et al. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells. Lung Cancer 2009;66(3):298–304. doi: 10.1016/j.lungcan.2009.02.019
   PubMed Web of Science ®Google Scholar
• Marikovsky M, Nevo N, Vadai E, Harris-Cerruti C. Cu/Zn superoxide dismutase plays a role in angiogenesis. Int J Cancer 2002;97(1):34–41. doi: 10.1002/ijc.1565
   PubMed Web of Science ®Google Scholar
• Pani G, Galeotti T, Chiarugi P. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 2010;29(2):351–78. doi: 10.1007/s10555-010-9225-4
   PubMed Web of Science ®Google Scholar
• De Bona KS, Bellé LP, Bittencourt PE, Bonfanti G, Cargnelluti LO, Pimentel VC, et al. Erythrocytic enzymes and antioxidant status in people with type 2 diabetes: beneficial effect of Syzygium cumini leaf extract in vitro. Diabetes Res Clin Pract 2011;94(1):84–90. doi: 10.1016/j.diabres.2011.06.008
   PubMed Web of Science ®Google Scholar
• Zanini D, Schmatz R, Pelinson LP, Pimentel VC, Costa P, Cardoso AM, et al. Ectoenzymes and cholinesterase activity and biomarkers of oxidative stress in patients with lung cancer. Mol Cell Biochem 2013;374(1–2):137–48. doi: 10.1007/s11010-012-1513-6
   PubMed Web of Science ®Google Scholar
• Klarod K, Hongsprabhas P, Khampitak T, Wirasorn K, Kiertiburanakul S, Tangrassameeprasert R, et al. Serum antioxidant levels and nutritional status in early and advanced stage lung cancer patients. Nutrition 2011;27(11–12):1156–60. doi: 10.1016/j.nut.2010.12.019
   PubMed Web of Science ®Google Scholar
• Gupta A, Srivastava S, Prasad R, Natu SM, Mittal B, Negi MP, et al. Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response. Respirology 2010;15(2):349–56. doi: 10.1111/j.1440-1843.2009.01703.x
   PubMed Web of Science ®Google Scholar
• Seven A, Erbil Y, Seven R, Inci F, Gülyasar T, Barutcu B, et al. Breast cancer and benign breast disease patients evaluated in relation to oxidative stress. Cancer Biochem Biophys 1998;16(4):333–45.
   PubMedGoogle Scholar
• Gerber M, Astre C, Segala C, Saintot M, Scali J, Simony-Lafontaine J, et al. Oxidant–antioxidant status alterations in cancer patients: relationship to tumor progression. J Nutr 1996;126(4):1201–7.
   PubMed Web of Science ®Google Scholar
• Manabe T, Asano N, Yoshimura T, Suwa H, Imamura T, Ohshio G. Effect of synthetic protease inhibitor on histologic changes and free radical activity in hamsters with pancreas cancer. Scand J Gastroenterol 1993;28(8):719–24. doi: 10.3109/00365529309098280
   PubMed Web of Science ®Google Scholar
• Thanan R, Pairojkul C, Pinlaor S, Khuntikeo N, Wongkham C, Sripa B, et al. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis. Free Radic Biol Med 2013;65:1464–72. doi: 10.1016/j.freeradbiomed.2013.07.034
   PubMed Web of Science ®Google Scholar
• Mantovani G, Macciò A, Madeddu C, Mura L, Gramignano G, Lusso MR, et al. Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. J Mol Med 2003;81(10):664–73. doi: 10.1007/s00109-003-0476-1
   PubMed Web of Science ®Google Scholar
• Macciò A, Madeddu C, Gramignano G, Mulas C, Floris C, Sanna E, et al. A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life. Gynecol Oncol 2012;124(3):417–25. doi: 10.1016/j.ygyno.2011.12.435
   PubMed Web of Science ®Google Scholar
• Mantovani G, Macciò A, Madeddu C, Mura L, Gramignano G, Lusso MR, et al. Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. Int J Cancer 2002;98(1):84–91. doi: 10.1002/ijc.10143
   PubMed Web of Science ®Google Scholar
• Mantovani G, Madeddu C. Cyclooxygenase-2 inhibitors and antioxidants in the treatment of cachexia. Curr Opin Support Palliat Care 2008;2(4):275–81. doi: 10.1097/SPC.0b013e32830f47e4
   PubMedGoogle Scholar